Home Top healthcare stock fund focuses on costs, orphan drugs in 2016
 

Keywords :   


Top healthcare stock fund focuses on costs, orphan drugs in 2016

2015-11-18 01:43:18| Biotech - Topix.net

Healthcare companies that can either contain costs or develop medications to treat rare diseases, known as orphan drugs, will be the most likely to outperform in the coming year, said John Fraunces, whose Turner Medical Sciences Long/Short fund is among the top performing healthcare funds over the last 5 years. Fraunces, who co-manages the $134 million fund, said he has been increasing his short positions, or bets that shares will decline, on companies that face increased price pressure for high-priced drugs.

Tags: top stock costs fund

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.06Potential Tropical Cyclone One Graphics
18.06Atlantic Tropical Weather Outlook
18.06Potential Tropical Cyclone One Public Advisory Number 1A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Could brain-like computers be a 'competition killer'?
18.06Low investment blocking UK growth, says think tank
18.06Eastern North Pacific Tropical Weather Outlook
18.06Boeing boss admits culture 'far from perfect'
More »